Literature DB >> 12407516

Brain metastases in melanoma: a European perspective.

Emma Cattell1, Charles Kelly, Mark R Middleton.   

Abstract

CNS involvement is a common feature of metastatic melanoma. Despite this, there is little evidence upon which clinicians can base decisions about treatment. The short prognosis and significant symptoms usually associated with melanoma brain metastases have excluded these patients from clinical trials. In Europe the standard treatment involves whole brain radiotherapy, although selected centers offer other modalities, including surgery, radiosurgery, and chemotherapy. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407516     DOI: 10.1053/sonc.2002.35246

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  3 in total

Review 1.  Current treatment options of brain metastases and outcomes in patients with malignant melanoma.

Authors:  Jadwiga Nowak-Sadzikowska; Tomasz Walasek; Jerzy Jakubowicz; Paweł Blecharz; Marian Reinfuss
Journal:  Rep Pract Oncol Radiother       Date:  2015-12-29

2.  Genes overexpressed in different human solid cancers exhibit different tissue-specific expression profiles.

Authors:  Jacob Bock Axelsen; Jacob Bock-Axelsen; Joseph Lotem; Leo Sachs; Eytan Domany
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-30       Impact factor: 11.205

3.  Current concepts of metastasis in melanoma.

Authors:  Blazej Zbytek; J Andrew Carlson; Jacqueline Granese; Jeffrey Ross; Martin C Mihm; Andrzej Slominski
Journal:  Expert Rev Dermatol       Date:  2008-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.